FDA grants approval of metoclopramide nasal spray (Gimoti) for diabetic gastroparesis

Gimoti is a novel metoclopramide nasal spray approved by the FDA for the relief of symptoms associated with acute and recurrent diabetic gastroparesis. There are no current regulatory plans for the EU or UK.

Source:

Biospace Inc.